Interferon gamma, a possible therapeutic approach for late-stage prostate cancer?

Abstract

Prostate cancer is the most frequently diagnosed cancer in men in Western countries. Clinically localized disease can be cured with surgery or radiotherapy, but once the disease has advanced or spread, there are no curative treatments. This review examines the potential utility of cytokines, in particular interferon gamma (IFNgamma), in the treatment of clinically advanced prostate cancer.